Alerts will be sent to your verified email
Verify Email
MERCURYLAB
|
Mercury Laboratories
|
Bharat Immunological
|
Onyx Biotec
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.35 % | -29.83 % | 14.26 % |
|
5yr average Equity Multiplier
|
1.57 | 3.08 | 2.82 |
|
5yr Average Asset Turnover Ratio
|
1.06 | 0.61 | 0.87 |
|
5yr Avg Net Profit Margin
|
6.89 % | -18.38 % | 5.93 % |
|
Price to Book
|
1.95 | 1.33 | 0.0 |
|
P/E
|
25.48 | 0.0 | 29.88 |
|
5yr Avg Cash Conversion Cycle
|
32.22 Days | 206.63 Days | 16.09 Days |
|
Inventory Days
|
33.99 Days | 125.06 Days | 40.2 Days |
|
Days Receivable
|
104.38 Days | 61.4 Days | 69.43 Days |
|
Days Payable
|
169.31 Days | 117.81 Days | 87.57 Days |
|
5yr Average Interest Coverage Ratio
|
14.51 | -2.32 | 5.06 |
|
5yr Avg ROCE
|
14.24 % | -44.64 % | 12.24 % |
|
5yr Avg Operating Profit Margin
|
12.03 % | -18.7 % | 13.24 % |
|
5 yr average Debt to Equity
|
0.15 | 0.71 | 1.2 |
|
5yr CAGR Net Profit
|
11.83 % | 23.51 % | -1.99 % |
|
5yr Average Return on Assets
|
7.32 % | -10.1 % | 5.44 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.66 % | 59.25 % | 65.1 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Mercury Laboratories
|
Bharat Immunological
|
Onyx Biotec
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|